Need all Congresses? Press Enter for expanded federal results.

Drug safety, medical device, and laboratory regulation

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
1,287
Coverage
110th-119th
Current view
All Congresses
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
1,287 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 5582
Patients Deserve Price Tags Act
119th Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. September 26, 2025
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
119th Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3. September 17, 2025
HR 4709
Newborn Screening Saves Lives Reauthorization Act of 2025
119th Forwarded by Subcommittee to Full Committee by Voice Vote. September 10, 2025
HR 4273
Over-the-Counter Monograph Drug User Fee Amendments
119th Placed on the Union Calendar, Calendar No. 254. September 17, 2025
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
119th Placed on the Union Calendar, Calendar No. 138. June 25, 2025
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
119th Received in the Senate. September 30, 2025
HR 1657
Humane Cosmetics Act of 2025
119th Referred to the House Committee on Energy and Commerce. February 27, 2025
HR 1632
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
119th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. February 26, 2025
HR 1539
Medical Device Electronic Labeling Act
119th Referred to the House Committee on Energy and Commerce. February 24, 2025
HR 1532
Scientific EXPERT Act of 2025
119th Referred to the House Committee on Energy and Commerce. February 24, 2025
HR 1525
Protecting Life from Chemical Abortions Act
119th Referred to the House Committee on Energy and Commerce. February 24, 2025
HR 1463
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relati...
119th Referred to the House Committee on Energy and Commerce. February 21, 2025
HR 1266
Combating Illicit Xylazine Act
119th Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. February 12, 2025
HR 1262
Mikaela Naylon Give Kids a Chance Act
119th Received in the Senate. December 2, 2025
HR 1117
Responsibility in Drug Advertising Act of 2025
119th Referred to the House Committee on Energy and Commerce. February 7, 2025
HR 1060
Modern Authentication of Pharmaceuticals Act of 2025
119th Referred to the House Committee on Energy and Commerce. February 6, 2025
HR 1051
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a...
119th Referred to the House Committee on Energy and Commerce. February 6, 2025
HR 950
Saving Seniors Money on Prescriptions Act
119th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. February 4, 2025
HR 843
Prompt Approval of Safe Generic Drugs Act
119th Referred to the House Committee on Energy and Commerce. January 31, 2025
HR 795
Pregnancy Is Not an Illness Act of 2025
119th Referred to the House Committee on Energy and Commerce. January 28, 2025
HR 706
DHS Biodetection Improvement Act
119th Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs. March 12, 2025
HR 685
SAVE Moms and Babies Act of 2025
119th Referred to the House Committee on Energy and Commerce. January 23, 2025
HR 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strat...
119th Referred to the House Committee on Energy and Commerce. January 23, 2025
HR 89
Prescription Freedom Act of 2025
119th Referred to the House Committee on Energy and Commerce. January 3, 2025
S 2658
Medication Affordability and Patent Integrity Act
119th Committee on Health, Education, Labor, and Pensions. Hearings held. March 19, 2026
S 2355
Patients Deserve Price Tags Act
119th Committee on Health, Education, Labor, and Pensions. Hearings held. March 19, 2026
S 2342
Intelligence Authorization Act for Fiscal Year 2026
119th By Senator Cotton from Select Committee on Intelligence filed written report. Report No. 119-51. Minority views filed. July 29, 2025
S 2292
Over-the-Counter Monograph Drug User Fee Amendments
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 152. September 8, 2025
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 112. July 10, 2025
S 1097
Interagency Patent Coordination and Improvement Act of 2025
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 41. April 10, 2025
S 1095
Stop STALLING Act
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 45. April 10, 2025
S 1041
Affordable Prescriptions for Patients Act
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 44. April 10, 2025
S 1040
Drug Competition Enhancement Act
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 43. April 10, 2025
S 822
Scientific EXPERT Act of 2025
119th Read twice and referred to the Committee on Health, Education, Labor, and Pensions. March 3, 2025
S 705
Innovation in Pediatric Drugs Act of 2025
119th Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347) February 25, 2025
S 641
Safe and Affordable Drugs from Canada Act of 2025
119th Read twice and referred to the Committee on Health, Education, Labor, and Pensions. February 19, 2025
S 545
Combating Illicit Xylazine Act
119th Placed on Senate Legislative Calendar under General Orders. Calendar No. 372. April 15, 2026
S 483
Responsibility in Drug Advertising Act of 2025
119th Read twice and referred to the Committee on Health, Education, Labor, and Pensions. February 6, 2025
S 355
FDA Modernization Act 3.0
119th Held at the desk. December 17, 2025
HR 9979
Scientific EXPERT Act of 2024
118th Referred to the House Committee on Energy and Commerce. October 11, 2024